Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
Holding MIRM?
Track your performance easily

Mirum Pharmaceuticals (MIRM) Financial Statements

645 Followers

Mirum Pharmaceuticals Financial Overview

Mirum Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.343; its P/E ratio is -17.37; Mirum Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 77.88M$ 69.22M$ 69.55M$ 47.73M$ 32.50M
Gross Profit$ 77.88M$ 69.22M$ 44.53M$ 47.73M-
EBIT$ -24.00M$ -3.25M$ -31.87M$ -23.34M$ -73.72M
EBITDA$ -17.74M$ 2.83M$ -26.38M-$ -72.86M
Net Income Common Stockholders$ -24.64M$ -25.28M$ -35.66M$ -47.28M$ -74.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 278.37M$ 302.84M$ 286.33M$ 306.03M$ 329.95M
Total Assets$ 660.75M$ 651.96M$ 646.62M$ 650.64M$ 443.57M
Total Debt$ 316.56M$ 307.52M$ 308.14M$ 307.97M$ 307.83M
Net Debt$ 38.19M$ 4.68M$ 21.82M$ 1.94M$ -22.13M
Total Liabilities$ 431.77M$ 417.36M$ 397.95M$ 381.56M$ 364.98M
Stockholders Equity$ 228.94M$ 234.60M$ 248.67M$ 269.08M$ 78.60M
Cash Flow-
Free Cash Flow$ -14.58M$ 15.20M$ -21.62M-$ -17.40M
Operating Cash Flow$ -3.80M$ 15.21M$ -16.62M$ -18.22M$ -2.33M
Investing Cash Flow$ -72.72M$ -13.00K$ -2.00M$ -182.76M$ 35.55M
Financing Cash Flow$ 7.29M$ 1.21M$ 1.78M$ 207.13M$ 114.71M
Currency in USD

Mirum Pharmaceuticals Earnings and Revenue History

Mirum Pharmaceuticals Debt to Assets

Mirum Pharmaceuticals Cash Flow

Mirum Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis